|
KIAA0406 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.68220000000119E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.39039999975155E-07 |
| Normal-vs-Stage2 |
8.829900E-02 |
| Normal-vs-Stage3 |
6.157700E-02 |
| Normal-vs-Stage4 |
1.447440E-01 |
| Stage1-vs-Stage2 |
1.891240E-01 |
| Stage1-vs-Stage3 |
4.516100E-02 |
| Stage1-vs-Stage4 |
1.071630E-01 |
| Stage2-vs-Stage3 |
8.452000E-01 |
| Stage2-vs-Stage4 |
8.270200E-01 |
| Stage3-vs-Stage4 |
9.564400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.91846999999523E-05 |
| Normal-vs-AfricanAmerican |
8.146200E-01 |
| Normal-vs-Asian |
1.239680E-03 |
| Caucasian-vs-AfricanAmerican |
2.549600E-02 |
| Caucasian-vs-Asian |
3.586000E-01 |
| AfricanAmerican-vs-Asian |
4.669700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.009700E-04 |
| Normal-vs-Female |
1.389250E-04 |
| Male-vs-Female |
5.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.839230E-01 |
| Normal-vs-Age(41-60Yrs) |
3.90470000000143E-05 |
| Normal-vs-Age(61-80Yrs) |
1.761920E-03 |
| Normal-vs-Age(81-100Yrs) |
6.818400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.361000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.994600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.135000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.502400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.767610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.538000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.92080000005479E-06 |
| Normal-vs-Grade 2 |
1.50587999999674E-05 |
| Normal-vs-Grade 3 |
4.323600E-03 |
| Normal-vs-Grade 4 |
4.337200E-01 |
| Grade 1-vs-Grade 2 |
1.079430E-01 |
| Grade 1-vs-Grade 3 |
4.960300E-02 |
| Grade 1-vs-Grade 4 |
9.364500E-03 |
| Grade 2-vs-Grade 3 |
1.751380E-01 |
| Grade 2-vs-Grade 4 |
1.792270E-02 |
| Grade 3-vs-Grade 4 |
2.010200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.19569999959646E-07 |
| Normal-vs-ccB subtype |
1.400740E-03 |
| ccA subtype-vs-ccB subtype |
2.215800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.750330E-04 |
| Normal-vs-N1 |
6.901800E-02 |
| N0-vs-N1 |
2.147000E-01 |
|
|
